Document is current
Any future updates will be listed below
-
Authors
Syed, Umer
Subramanian, Anuradhaa
Wraith, David C.
Lord, Janet M.
McGee, Kirsty
Ghokale, Krishna
Nirantharakumar, Krishnarajah
Haroon, Shamil
- License Information
-
More Information
Article History
Received: 19 January 2023
Accepted: 24 August 2023
First Online: 21 September 2023
Declarations
:
: This study consists of secondary data analysis of pseudo-anonymised data from the CPRD Aurum database and thus approval was only required to access the database. The project was reviewed and approved by the CPRD Independent Scientific Advisory Committee (study #21_000712) on the 24th of February 2022.
: Not applicable.
: SH reports receiving funding from NIHR and UKRI. US report no competing interests. AS has no declarations during the study period; after the study was completed, she has taken a post in AstraZeneca. JL receives grant funding from NIHR, UKRI, Versus Arthritis, The Scar Free Foundation, FOREUM, and Bayer Healthcare for which also she acts as a consultant.
